探索刺激性肠综合征和多囊性卵巢综合征之间的遗传联系:双向孟德尔随机化和机器学习方法
Ziwei Gao1, Zhenglin Mei2, Yujun Zhang2
1Department of Gastroenterology, Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang Province, China.
Endocrine, metabolic & immune disorders drug targets
|April 18, 2025
概括
多囊性卵巢综合征 (PCOS) 具有因果影响,影响着刺激性肠综合征 (IBS),但不是相反. CD14和CASP1基因可以作为两种疾病的共享诊断标记,提供对它们的生物联系的见解.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 遗传学 遗传学 是一个
背景情况:
- 多囊性卵巢综合征 (PCOS) 和刺激性肠综合征 (IBS) 呈现出已知的相关性.
- 这种关联的确切方向性和生物学机制需要阐明.
研究的目的:
- 调查PCOS和IBS之间的因果关系.
- 为了确定共享的生物学途径和潜在的诊断生物标志物,这两种疾病.
主要方法:
- 使用双向门德尔随机化 (MR) 分析来评估因果关系.
- 使用了生物信息学方法,包括基因丰富和蛋白质-蛋白质相互作用网络分析.
- 机器学习算法 (LASSO,SVM) 和ROC分析确定了诊断标记.
- 单样样本基因组丰富分析 (ssGSEA) 评估了免疫细胞透.
主要成果:
- 核磁共振分析显示,PCOS对IBS有显著的因果作用 (OR = 1.034,P = 0.029).
- 没有发现IBS与PCOS有显著的因果关系.
- CD14和CASP1被确定为这两种疾病的关键诊断生物标志物,与免疫细胞透有关.
结论:
- 从PCOS到IBS之间存在显著的积极因果关系.
- 已识别的基因CD14和CASP1代表了潜在的共享诊断标记.
- 这些发现有助于理解PCOS和IBS之间的相互作用.
相关概念视频
Irritable Bowel Syndrome I: Introduction
203
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
203
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
96
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
96
Chronic Bowel Disorders: Introduction
310
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
310
Drugs for Treatment of Diarrhea-Predominant IBS
117
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
117
Irritable Bowel Syndrome III: Medical and Nursing Management
117
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
117
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
236
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
236


